Roche and Novo-backed small molecule therapy developer Aligos Therapeutics has floated in an initial public offering priced in the middle of its range.

Nan Fung-backed hearing aid producer Eargo's shares opened at double its IPO price after it floated above its range.

Eli Lilly will acquire the AbbVie-backed neurological disease therapy developer in a $135m transaction that could top $1.2bn with milestone payments.

NTU spinout Nanofilm Technologies has seemingly filed a draft prospectus with a view of listing on the domestic Singapore Stock Exchange.

AMS, a developer of energy value assessment software, had raised $52m from investors including Engie, AGL Energy, Southern Company and GE Ventures.

Cuna Mutual's CMFG subsidiary had led digital lending software provider CuneXus' series A round three years ago.

SoftBank has exited the electronic health record platform through a $32.7m acquisition by medical school operator Afya.

Codiak – based on research at Gothenburg and MD Anderson Cancer Center – has succeeded in going public after previously cancelling plans.

The Tencent-backed retail chain floated well above its range in New York and its shares have risen some 40% post-IPO.

Tencent and Comcast are also set to exit the African payment tool provider in a purchase by fellow investor Stripe reportedly sized at more than $200m.